Since the REIC/Dkk-3 protein differentiates CD14+ monocytes into the DC phenotype (33), the REIC/Dkk-3 protein overexpressed and secreted by Ad-REIC transfection at the tumor site differentiates and activates DCs. This evidence concerns the gene DKK3 and neoplasm.